NO20013971L - Fremgangsmåte ved fremstilling av (2R)-2-propyloktansyre - Google Patents
Fremgangsmåte ved fremstilling av (2R)-2-propyloktansyreInfo
- Publication number
- NO20013971L NO20013971L NO20013971A NO20013971A NO20013971L NO 20013971 L NO20013971 L NO 20013971L NO 20013971 A NO20013971 A NO 20013971A NO 20013971 A NO20013971 A NO 20013971A NO 20013971 L NO20013971 L NO 20013971L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- propyloctanoic acid
- acid
- propyloctanoic
- octanoic acid
- Prior art date
Links
- YCYMCMYLORLIJX-SNVBAGLBSA-N (2r)-2-propyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CCC YCYMCMYLORLIJX-SNVBAGLBSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
- RXAINMDCYOMAHC-SNVBAGLBSA-N (2s)-2-prop-2-enyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CC=C RXAINMDCYOMAHC-SNVBAGLBSA-N 0.000 abstract 1
- DUQSBRQHALCSLC-SNVBAGLBSA-N (2s)-2-prop-2-ynyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CC#C DUQSBRQHALCSLC-SNVBAGLBSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 238000006317 isomerization reaction Methods 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/42—Platinum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
- B01J21/18—Carbon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3975899 | 1999-02-18 | ||
| PCT/JP2000/000900 WO2000048982A1 (en) | 1999-02-18 | 2000-02-17 | Process for the preparation of (2r)-2-propyloctanoic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013971D0 NO20013971D0 (no) | 2001-08-15 |
| NO20013971L true NO20013971L (no) | 2001-08-15 |
Family
ID=12561862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013971A NO20013971L (no) | 1999-02-18 | 2001-08-15 | Fremgangsmåte ved fremstilling av (2R)-2-propyloktansyre |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6608221B1 (de) |
| EP (3) | EP1714956A1 (de) |
| JP (2) | JP4752989B2 (de) |
| KR (1) | KR100666423B1 (de) |
| CN (4) | CN101100422A (de) |
| AT (1) | ATE359256T1 (de) |
| AU (1) | AU776927B2 (de) |
| BR (1) | BR0008261A (de) |
| CA (1) | CA2364308C (de) |
| DE (1) | DE60034316T2 (de) |
| ES (1) | ES2283287T3 (de) |
| HU (1) | HUP0200358A3 (de) |
| MX (1) | MXPA01008241A (de) |
| NO (1) | NO20013971L (de) |
| NZ (1) | NZ513569A (de) |
| RU (1) | RU2297406C2 (de) |
| TW (1) | TWI268921B (de) |
| WO (1) | WO2000048982A1 (de) |
| ZA (1) | ZA200106500B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI268921B (en) * | 1999-02-18 | 2006-12-21 | Ono Pharmaceutical Co | A process for preparing (2R)-2-propyloctanoic acid |
| WO2003007992A1 (en) | 2001-07-18 | 2003-01-30 | Ono Pharmaceutical Co., Ltd. | Remedies for brain ischemic diseases |
| JP2005298334A (ja) * | 2001-12-19 | 2005-10-27 | Ono Pharmaceut Co Ltd | 新規な中間体化合物およびそれを用いる化合物の製造方法 |
| US8053599B2 (en) * | 2003-10-03 | 2011-11-08 | Ono Pharmaceutical Co., Ltd. | Drug containing (2R)-2-propyloctanoic acid as the active ingredient |
| BRPI0414968A (pt) * | 2003-10-03 | 2006-11-07 | Ono Pharmaceutical Co | preparação de infusão contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo |
| US7928143B2 (en) * | 2003-10-03 | 2011-04-19 | Ono Pharmaceutical Co., Ltd. | Method for preventing and/or treating neurodegenerative diseases |
| EP1741697B1 (de) * | 2004-04-28 | 2012-12-19 | Ono Pharmaceutical Co., Ltd. | Kristall, enthaltend (2r)-2-propyloctansäure und dibenzylamin |
| US7495029B2 (en) * | 2004-11-16 | 2009-02-24 | Merck & Co., Inc | Prodrugs of (2R)-2-propyloctanoic acid for the treatment of stroke |
| JPWO2006075596A1 (ja) * | 2005-01-13 | 2008-06-12 | 株式会社クラレ | ２−アリルカルボン酸化合物の製造方法 |
| US20090082455A1 (en) | 2005-03-15 | 2009-03-26 | Ono Pharmaceutical Co. Lted | Therapeutic agent for ophthalmic disease |
| JP5050851B2 (ja) | 2005-06-27 | 2012-10-17 | 小野薬品工業株式会社 | 疼痛治療剤 |
| CA2625341A1 (en) | 2005-10-18 | 2007-04-26 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| WO2007072902A1 (ja) | 2005-12-22 | 2007-06-28 | Ono Pharmaceutical Co., Ltd. | 急性期脳梗塞治療剤 |
| US20090118542A1 (en) * | 2006-02-16 | 2009-05-07 | Shigeya Yamazaki | Process for Production of Optically Active Carboxlic Acid Compound |
| EP2015741A4 (de) * | 2006-05-04 | 2009-12-23 | Merck & Co Inc | Histondeacetylase-hemmer zur behandlung von neurodegeneration |
| CN102417445B (zh) * | 2011-11-05 | 2013-11-13 | 中国科学院山西煤炭化学研究所 | 一种由马来酸合成丁二酸的方法 |
| CN102675166B (zh) * | 2012-05-11 | 2014-03-26 | 山东齐都药业有限公司 | 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法 |
| CN102786407B (zh) * | 2012-08-15 | 2014-04-16 | 湖北大学 | 一种制备(2r)-2-丙基辛酸的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2317019A1 (de) | 1972-04-27 | 1973-11-08 | Upjohn Co | Neue 4,5-didehydro-prostaglandine |
| JPH0672123B2 (ja) * | 1986-08-21 | 1994-09-14 | セントラル硝子株式会社 | トリフルオロメチル基を有するシクロヘキサンカルボン酸の製造方法 |
| JP2868183B2 (ja) * | 1988-02-29 | 1999-03-10 | 株式式社三和化学研究所 | 光学活性を有する４−オキソ−１−ベンゾピラン−２−カルボン酸誘導体の製法、その合成用中間体並びに該中間体の製法 |
| US5202474A (en) * | 1989-06-22 | 1993-04-13 | Monsanto Company | Asymmetric catalytic hydrogenation of α-arylpropenoic acids |
| EP0632008B1 (de) | 1993-06-01 | 1998-02-04 | Ono Pharmaceutical Co., Ltd. | Pentansäurederivate |
| JP3032447B2 (ja) | 1995-04-24 | 2000-04-17 | 小野薬品工業株式会社 | 光学活性な２−プロピルオクタン酸の製造方法 |
| JP3084345B2 (ja) * | 1995-04-26 | 2000-09-04 | 小野薬品工業株式会社 | 光学活性な２−プロピルオクタン酸の製造方法 |
| TW509672B (en) | 1998-05-12 | 2002-11-11 | Ono Pharmaceutical Co | Novel intermediate compounds and processes for the production of optical active octanoic acid derivatives |
| TWI268921B (en) * | 1999-02-18 | 2006-12-21 | Ono Pharmaceutical Co | A process for preparing (2R)-2-propyloctanoic acid |
| EP1741697B1 (de) * | 2004-04-28 | 2012-12-19 | Ono Pharmaceutical Co., Ltd. | Kristall, enthaltend (2r)-2-propyloctansäure und dibenzylamin |
-
2000
- 2000-02-16 TW TW089102580A patent/TWI268921B/zh not_active IP Right Cessation
- 2000-02-17 AU AU25730/00A patent/AU776927B2/en not_active Ceased
- 2000-02-17 AT AT00904007T patent/ATE359256T1/de not_active IP Right Cessation
- 2000-02-17 ES ES00904007T patent/ES2283287T3/es not_active Expired - Lifetime
- 2000-02-17 CN CNA2006100997275A patent/CN101100422A/zh active Pending
- 2000-02-17 KR KR1020017010357A patent/KR100666423B1/ko not_active Expired - Fee Related
- 2000-02-17 CN CNB2004100927127A patent/CN100430364C/zh not_active Expired - Fee Related
- 2000-02-17 NZ NZ513569A patent/NZ513569A/xx not_active IP Right Cessation
- 2000-02-17 EP EP06012511A patent/EP1714956A1/de not_active Withdrawn
- 2000-02-17 MX MXPA01008241A patent/MXPA01008241A/es active IP Right Grant
- 2000-02-17 EP EP00904007A patent/EP1153910B1/de not_active Expired - Lifetime
- 2000-02-17 WO PCT/JP2000/000900 patent/WO2000048982A1/ja not_active Ceased
- 2000-02-17 CA CA002364308A patent/CA2364308C/en not_active Expired - Fee Related
- 2000-02-17 JP JP2000599723A patent/JP4752989B2/ja not_active Expired - Fee Related
- 2000-02-17 BR BR0008261-9A patent/BR0008261A/pt not_active Application Discontinuation
- 2000-02-17 CN CNA2006101002245A patent/CN1907938A/zh active Pending
- 2000-02-17 RU RU2001125501/04A patent/RU2297406C2/ru active
- 2000-02-17 DE DE60034316T patent/DE60034316T2/de not_active Expired - Lifetime
- 2000-02-17 EP EP06012510A patent/EP1721882A1/de not_active Withdrawn
- 2000-02-17 CN CNB008040133A patent/CN1183082C/zh not_active Expired - Fee Related
- 2000-02-17 HU HU0200358A patent/HUP0200358A3/hu unknown
- 2000-02-17 US US09/890,651 patent/US6608221B1/en not_active Expired - Fee Related
-
2001
- 2001-08-07 ZA ZA200106500A patent/ZA200106500B/en unknown
- 2001-08-15 NO NO20013971A patent/NO20013971L/no not_active Application Discontinuation
-
2010
- 2010-05-20 JP JP2010116000A patent/JP5343925B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20013971L (no) | Fremgangsmåte ved fremstilling av (2R)-2-propyloktansyre | |
| Endo et al. | Mode of inhibition of β-hydroxydecanoyl thioester dehydrase by 3-decynoyl-N-acetylcysteamine | |
| Kimura et al. | Evidence for two different forms of guanylate cyclase in rat heart | |
| Baertschi et al. | Absolute configuration of cis-12-oxophytodienoic acid of flaxseed: implications for the mechanism of biosynthesis from the 13 (S)-hydroperoxide of linolenic acid | |
| IE57200B1 (en) | Dopamine-beta-hydroxylase inhibitors | |
| DE3689235D1 (de) | Herstellung von basischen Aluminiumhalogeniden. | |
| Boeynaems et al. | Transformation of arachidonic acid into an iodolactone by the rat thyroid. | |
| ES2020981B3 (es) | Fenilsulfonamidas sustituidas. | |
| FI892016A0 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten, mahdollisesti -substituoitujen 4-(-kinolin-2-yyli-metoksi)-fenyylietikkahappojen ja -esterien valmistamiseksi | |
| AU2275397A (en) | Troponin subunits and fragments useful as angiogenesis inhibitors | |
| BR0016665A (pt) | Composição alvejante, e, métodos de alvejamento e de preparação de uma composição alvejante | |
| BR9917007A (pt) | Moduladores de ccr5 | |
| NO962490L (no) | Orale formuleringer av S(+)-ibuprofen | |
| JPS51128993A (en) | Process for preparing new polypeptides | |
| Crouch et al. | Interaction of calmodulin with skeletal muscle myosin light chain kinase | |
| Majeski et al. | Controlled potential oxidation of anthracene in acetonitrile. II | |
| JPS55108860A (en) | Hydroxypropylltriazole*its manufacture and use as medicine | |
| IE830607L (en) | Imidazolylphenylpyridazinones | |
| ES549776A0 (es) | Procedimiento para la preparacion de pirrolo-bencimidazoles | |
| Sourkes et al. | Reduction of methionine sulfoxides by Escherichia coli | |
| AU4152893A (en) | Preparation of basic aluminium halides | |
| Jackson et al. | Effect of heat on some collagen cross-links | |
| Gershon et al. | Amino acid analogs. 2. 3-Fluoroamino acids. 1. Chain length three to seven carbon atoms | |
| AU581185B2 (en) | Process for the racemization of optically active aminoacids | |
| DK0471252T3 (da) | N-Alkyl-N-(meth)acryloyloxyalkylcarboxamider af aromatiske carboxylsyrer og af aromatiske carboxylsyreanhydrider samt klæbestoffer, som indeholder disse forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |